RXO INC
RXONYSETrading Snapshot
- Day Range
- $27.48 β $28.62
- 52-Week Range
- $10.43 β $29.90
- Volume (shares)
- 3,419,173
- Avg Volume (shares)
- β
- Shares Outstanding
- 165.0M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $5.74B
- Last Q Revenue
- $1.77B
- P/E Ratio
- -45.0
- P/S Ratio
- 0.7x
- EPS (TTM)
- $-0.62
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.6%
RXO INC
RXOAbout RXO INC
RXO, Inc., headquartered in Charlotte, North Carolina, functions as a freight broker specializing in full truckload transportation services across the United States. The company utilizes its unique digital marketplace to link clients with available truckload space. Beyond this core offering, RXO also provides a suite of related brokered services, including comprehensive managed logistics, local last-mile delivery, and international freight forwarding.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, RXO (RXO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced M

Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 20, 2026Insiders may stand to receive substantial financial benef

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq β SLN), Option Care Health, Inc. (Nasdaq β OPCH), RXO Inc. (NYSE β RXO), Sangoma Technologies Corporation (Nasdaq β SANG)
BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith

Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene

C.H. Robinson Bets Its AI Story on RXOβBut the Market Isn't Sold
Investors in C.H. Robinson Worldwide NASDAQ: CHRW have had a few days to react to the company's announcement of a stock-and-cash agreement to acquire RXO NYSE: RXO with an implied value of $5.8 billion.

Breakfast News: Week in Review
Yields hit a 24-year high as SpaceX borrows $40 billion for Nvidia chips, and moreβ¦